Wegovy is shown to reduce risk of heart attacks and strokes in some patients

, November 13, 2023
Pharma

The results of a large clinical trial suggest the obesity medication could also change the landscape of cardiovascular care.

For the first time, gene-editing provides hints for lowering cholesterol

, November 13, 2023
Pharma

Researchers have produced evidence that gene-editing can cut high cholesterol, a major risk factor for the nation's leading killer.

AstraZeneca eyes market for cheap Ozempic-like drug in pill form

, November 13, 2023
Pharma

Soriot envisions cosmetic weight-loss market, not just obesity.

First vaccine for chikungunya virus, an 'emerging global health threat,' gets FDA approval

, November 13, 2023
Pharma

Virus is spread by infected mosquitoes; vaccine is approved for those age 18 and up.

Lung cancer pill shows 'earth-shattering' results in 5-year study

, November 9, 2023
Pharma

Hackensack Meridian's Dr. Faiz Bhora shares his experience with Tagrisso in 'the era of personalized medicine'.

FDA approves Eli Lilly's diabetes drug Mounjaro for obesity under new name, Zepbound

, November 9, 2023
Pharma

The FDA approved the type 2 diabetes drug tirzepatide for use in chronic weight management Wednesday, making official the use of a medicine already widely prescribed off-label for weight loss.

Pages